Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VolitionRX Ltd VNRX

Healthcare Medical Instruments & Supplies
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and... see more

Recent & Breaking News (NYSEAM:VNRX)

VolitionRx Announces its European Colorectal Cancer Strategy

PR Newswire September 19, 2017

VolitionRx to Attend Two Major Conferences in Asia

PR Newswire September 15, 2017

Volition Granted Four Additional Patents

PR Newswire September 14, 2017

GVC Capital and Trickle Research Announce Preliminary Presenter Schedule for Inaugural Rocky Mountain MicroCap Conference in Denver on September 25, 2017

Marketwired September 7, 2017

VolitionRx Limited to Attend Multiple Conferences in September

PR Newswire September 6, 2017

Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers

PR Newswire August 22, 2017

VolitionRx Limited Announces Second Quarter 2017 Financial Results and Business Update

PR Newswire August 9, 2017

VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update

PR Newswire August 3, 2017

VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute

PR Newswire July 19, 2017

Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer Institute

PR Newswire July 18, 2017

Volition to Present at the EuropaColon Advocacy Masterclass and Exhibit at the European Society for Medical Oncology Gastrointestinal Cancer Congress

PR Newswire June 30, 2017

VolitionRx Limited Corrects an Earlier Announcement

PR Newswire June 27, 2017

VolitionRx Limited to Present at Multiple Investor Conferences in June

PR Newswire May 26, 2017

A new publication reports that 91% of colorectal cancers were detected at 90% specificity in a completed prospective trial using Volition's Nu.Q(TM) assays

PR Newswire May 18, 2017

VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update

PR Newswire May 11, 2017

VolitionRx Limited Announces Final Results from 8000 Patient Clinical Trial in Denmark to Evaluate the Performance of its Nu.Q(TM) Triage Test

PR Newswire May 9, 2017

VolitionRx Limited Schedules First Quarter 2017 Earnings Conference Call and Business Update

PR Newswire May 8, 2017

Volition makes progress with its Colorectal Cancer Screening Triage Test in both Asia and Europe

PR Newswire April 27, 2017

VolitionRx Appoints David Vanston as Chief Financial Officer

PR Newswire April 11, 2017

Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States

PR Newswire March 28, 2017